Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
This study is aimed to investigate whether treatment with Telmisartan is more effective than Candesartan in reducing the ischemic cardiovascular events in high-risk patients with cardiovascular disease.
Epistemonikos ID: 6fdd5f71686b1e7b95050b3ce0b4487e6a789bc4
First added on: May 05, 2024